课题基金 / 基金详情

Autotaxin Lysophophatidic acid pathway in bronchiolitis obliterans post-lung tran

Autotaxin Lysophophatidic acid pathway in bronchiolitis obliterans post-lung tran
肺移植后闭塞性细支气管炎中自分泌运动因子溶血磷脂酸途径
批准号:
8694759
负责人:
Vibha N Lama
金额:
$51.88万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2018-03-31
关键词:
AXIN2 proteinAcidsAffectAllograftingAnimalsBindingBiological AssayBiological MarkersBronchiolitis ObliteransBronchoalveolar LavageBronchoalveolar Lavage FluidCell Differentiation processCell NucleusCellsCessation of lifeChronicCicatrixClinical TrialsCollagenCyclin D1DataDeltastabDependencyDevelopmentDiseaseDrug TargetingEmbryoFamilyFelis catusFibrosisFutureGene TargetingGenerationsGenetic TranscriptionGlycogen Synthase Kinase 3HistologyHumanHuman ActivitiesHydroxyprolineImmunosuppressionInvestigationLabelLeadLigationLinkLipidsLungLung TransplantationLymphoidLysophosphatidylcholinesLysophospholipaseLysophospholipidsMediatingMembrane LipidsMesenchymalMesenchymeModelingMusOrgan TransplantationOutcomePathogenesisPathway interactionsPatientsPhenotypePhospholipase CPhosphorylationPlayPopulationProtein Kinase CPublishingReceiver Operator CharacteristicsReporterRespiratory physiologyRoleRouteSamplingSchemeSecondary toSignal PathwaySignal TransductionSignaling MoleculeSmall Interfering RNASolidSyndromeTCF Transcription FactorTestingTherapeuticTimeTissuesTomatoesTranscriptional ActivationTransgenic MiceTransplant RecipientsTransplantationUp-RegulationWorkactivating transcription factorautocrinecohortenhancer binding proteinextracellularfibrogenesisgraft failurehuman datain vivolung allograftlysophosphatidic acidmigrationmortalitynovelnovel therapeutic interventionnuclear factors of activated T-cellspreclinical studypreventprognosticprotein expressionpublic health relevanceresearch studytherapeutic targettranscription factorvzg-1 Receptor

项目摘要

项目成果

Vibha N Lama的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肺功能受损继发于纤维化瘢痕和小气道闭塞,称为闭塞性细支气管炎综合征(BOS),是肺移植后慢性移植物衰竭和死亡的主要原因。了解参与肺同种异体移植纤维形成的机制途径是该领域新治疗方法的关键。通过对人肺同种异体移植的间充质细胞(MCs)的研究,我们发现了一种新的MCs动员和激活的信号通路。在BOS患者的支气管肺泡灌洗(BAL)中可见供体来源的MCs数量增加。来自BOS肺的MCs也表现出稳定的活化表型,其特征是胶原蛋白和¿-catenin蛋白表达增加以及自身归一素(ATX)分泌活性增加。ATX是一种分泌的溶血磷脂酶D,它从膜脂中产生溶血磷脂酸(LPA),这是一种生物活性脂质,在组织纤维化中起作用。我们发表的工作揭示了一个独特的信号级联,通过LPA1连接和随后的磷酸激酶c介导的糖原合成酶激酶3激活,LPA导致-连环蛋白稳定和转录激活。新的初步数据表明,自分泌的ATX分泌和LPA1连接有助于稳定的¿-catenin和胶原蛋白上调,在人纤维化肺移植物分离的MCs中发现。此外,从BOS患者的BAL样本中发现LPA水平较高。这一人体数据促使我们提出了研究ATX-LPA-¿-catenin通路在BO发病机制中的体内作用的实验,并研究LPA1拮抗剂是否可以作为该疾病的潜在治疗选择。为了实现这些目标,我们建立了全肺小鼠原位肺移植模型,其中适度MHC错配导致28天气道纤维化的发展。在Aim 1中,我们建议使用该小鼠模型来研究ATX和LPA在体内常驻MCs和其他同种异体移植物细胞成分中的上调时间过程。我们将利用BAC荧光标记Foxf1的小鼠,Foxf1是一种在胚胎肺间质中发现的转录因子,在肺MCs中高表达,以特异性识别和研究移植物MCs。这些研究也将告诉我们移植物MCs在纤维形成中的作用。目的2将重点了解¿-catenin在MC分化中的作用,并剖析其影响细胞纤维化功能的机制。机制途径将在人类细胞中进行研究。然而,我们将利用报告小鼠(Axin2LacZ)跟踪异体移植物纤维形成过程中的-catenin转录活性,并测试LPA1连接在MC -catenin激活中的体内作用。在目标3中,我们将确定BAL样本中的LPA水平是否可以预测BOS的后续发展。重要的是,我们将在小鼠原位单肺移植模型中测试LPA1拮抗剂是否可以预防同种异体移植纤维化的发生或进展。这项工作将是对BOS中ATX/LPA/LPA1/¿-catenin信号传导的首次研究,并将为未来针对该途径在肺移植中的临床试验提供重要的理论依据。
英文摘要
DESCRIPTION (provided by applicant): Impaired lung function secondary to fibrotic scarring and obliteration of small airways, termed bronchiolitis obliterans syndrome (BOS), is the major cause of chronic graft failure and mortality following lung transplantation. Understanding mechanistic pathways involved in lung allograft fibrogenesis is the key to novel therapeutic approaches in this arena. Studies of mesenchymal cells (MCs) from human lung allografts have led us to target a novel signaling pathway of MC mobilization and activation. An increase in number of donor-derived MCs is seen in the bronchoalveolar lavage (BAL) of patients with BOS. MCs from BOS lungs also demonstrated a stable activated phenotype marked by an increased collagen and ¿-catenin protein expression as well as an increased autotaxin (ATX) secretory activity. ATX is a secreted lysophopholipase D which generates lysophosphatidic acid (LPA), a bioactive lipid with a role in tissue fibrosis, from membrane lipids. Our published work has revealed a unique signaling cascade where through LPA1 ligation and subsequent phosphokinase-C mediated glycogen synthase kinase-3¿ activation, LPA leads to ¿-catenin stabilization and transcriptional activation. New preliminary data demonstrates that autocrine ATX secretion and LPA1 ligation contributes to stable ¿-catenin and collagen upregulation noted in MCs isolated from human fibrotic lung grafts. Furthermore, LPA levels were noted to be higher in BAL samples from patients with BOS. This human data has led us to propose experiments investigating the in vivo role of ATX-LPA-¿-catenin pathway in pathogenesis of BO and to investigate if LPA1 antagonism can be a potential therapeutic option in this disease. To achieve these aims we have established a whole lung mouse orthotopic lung transplant model where a moderate MHC mismatch leads to development of airway fibrosis by day 28. In Aim 1, we propose to investigate the time course of ATX and LPA upregulation in the resident MCs and other cellular components of the allograft in vivo using this murine model. We will utilize mice with BAC florescent labeling of Foxf1, a transcription factor seen in embryonic lung mesenchyme and shown to be highly expressed in lung MCs, to specifically identify and study graft-resident MCs. These studies will also inform us of the role of graft-resident MCs in fibrogenesis. Aim 2 will focus on understanding the role of ¿-catenin in MC differentiation and dissecting the mechanisms by which it affects the cells fibrotic functions. The mechanistic pathways will be studied in human cells. However, we will utilize a reporter mouse (Axin2LacZ) to follow ¿-catenin transcriptional activity during allograft fibrogenesis and test the in vivo rol of LPA1 ligation in MC ¿-catenin activation. In Aim 3 we will determine if LPA levels in BAL samples can predict subsequent development of BOS. Importantly, we will test if LPA1 antagonist can prevent onset or progression of allograft fibrosis in the murine orthotopic single lung transplant model. The proposed work will be the first investigation of ATX/LPA/LPA1/ ¿-catenin signaling in BOS and will provide important rationale for future clinical trials targeting this pathway in lung transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction
  • 批准号:
    10864502
  • 项目类别:
  • 资助金额:
    $57.46万
  • 财政年份:
    2023
  • 负责人:
    Vibha N Lama
  • 依托单位:
Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation
Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation
Role of Resident Mesenchymal Stem Cells in Lung Allograft Rejection
国内基金
海外基金
抗禾谷镰刀菌3-Decalinoyltetramic Acids类天然产物的挖掘及基于“靶标垂钓”策略的作用机制研究
真菌中同一PKS-NRPS基因簇合成两种不同骨架tetramic acids机制研究
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究